Menu Content/Inhalt
Search  

PRESS RELEASES


   Order     Display # 
Date Item Title
20-Nov-2008 Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
13-Jul-2006 Debiopharm and Aurigene enter into an Agreement to identify and develop selective compounds for immuno-oncology targets
 
< Prev 1 Next >
Results 1 - 2 of 2